Q32 Bio

1 follower

‌

Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links

Org chart

Jodie Morrison

Acting CEO

Jodie Morrison

Collapse

Shelia Violette

Co-Founder & Chief Scientific Officer

Jason Campagna

Chief Medical Officer

David Appugliese

SVP & Head of People

Maria Marzilli

EVP, Corporate Strategy & Program Operations

Bill Lundberg

Independent Director

Fei Liu

Director, Pharmacology

Hong Wu, MD, PhD, DABT

Vp, Head Of Translational, Clinical Pharm, & Nonclinical Dev

Isidora Tošić

New Product Planning Manager

Theresa Carbeau

Director, CMC

Eric Bell

Senior Vice President Finance And Controller

Teams

+10

Finance & Strategic Planning

13 members

+10

Scientific Research & Development

13 members

Leadership Team

5 members

Clinical Operations

3 members

Quality Assurance & Regulatory Affairs

3 members

Offices

Similar companies

Calico

6 followers

Gameto

4 followers

Qualigen Therapeutics

3 followers

Tango Therapeutics

2 followers

Vera Therapeutics

2 followers

Apogee Therapeutics

1 follower

Cargo

1 follower

Capricor Therapeutics

1 follower

Aura Biosciences

1 follower

Edgewise Therapeutics

1 follower

Cartesian Therapeutics

1 follower

Explore companies